Fintel reports that on January 21, 2025, TD Cowen initiated coverage of Forte Biosciences (NasdaqCM:FBRX) with a Buy ...

Kimberly-Clark Corp (KMB) stock saw a modest uptick, ending the day at $127.22 which represents a slight increase of $0.57 or 0.45% from the prior close of $126.65. The stock opened at $126.77 and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.31% of ...

Elevated rates in LTL are starting to crack, driven by less discipline in fuel surcharges, according to a market report. LTL ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

TD Cowen’s price target suggests a potential downside of 0.84% from the company’s current price. Other equities research analysts also recently issued reports about the company.

In a report released today, Lance Vitanza from TD Cowen reiterated a Buy rating on Compass Diversified Holdings (CODI – Research Report), with ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $8.86.

Investing.com -- TD Cowen managing director Jaret Seiberg raised concerns that the recent issuance of a Donald Trump meme coin could pose challenges to bipartisan efforts to pass cryptocurrency market ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product.